Accueil › Cancer de la vessie › Caroline du Nord › Durham
Essais cliniques pour Cancer de la vessie à Durham, NC
20 études pour Cancer de la vessie recherchent des participants dans et autour de Durham (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Durham VA Medical Center, Durham
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Recrutement en coursPhase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Recrutement en coursPhase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Recrutement en coursPhase 1/2
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke University Hospital (location of scans), Durham
- Duke University Medical Center, Durham
- et 1 autres
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Recrutement en coursPhase 1
- Biorepository and Precision Pathology Center (BRPC), Durham
- Duke Cancer Institute, Durham
- Substrate Services Core Research Support (SSCRS), Durham
DESTINY-PANTUMOUR04
Recrutement en coursÉtude observationnelle
- Research Site, Durham
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Recrutement en coursPhase 1
- Duke University Medical Center - Duke Cancer Center, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Recrutement en coursÉtude observationnelle
- UNC- Chapel Hill, Chapel Hill · à 10 mi
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Recrutement en coursPhase 2
- University of North Carolina, Chapel Hill · à 10 mi
The Vanguard Study: Testing a New Way to Screen for Cancer
Recrutement en coursVolontaires sains bienvenus
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Recrutement en coursPhase 1
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill · à 10 mi
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Recrutement en coursPhase 2/3
- Research Site, Chapel Hill · à 10 mi
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Recrutement en coursPhase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · à 10 mi
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Recrutement en coursPhase 1/2
- Duke Health - Duke Cancer Center, Durham
- UNC Chapel Hill Hospital, Chapel Hill · à 10 mi
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Recrutement en coursÉtude observationnelle
- University of North Carolina, Chapel Hill · à 10 mi
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Recrutement en coursPhase 2
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · à 10 mi
- UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill · à 10 mi
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Recrutement en cours
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · à 10 mi
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
Recrutement en coursÉtude observationnelle
- Duke University, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Recrutement en coursPhase 1
- Duke Cancer Institute, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Chapel Hill · à 10 mi
Essais pour Cancer de la vessie dans d'autres villes
- New York City, NY35 études
- Nashville, TN31 études
- Houston, TX31 études
- Dallas, TX27 études
- Boston, MA26 études
- Washington, DC26 études
- Los Angeles, CA24 études
- Baltimore, MD24 études
- St. Louis, MO22 études
- Philadelphia, PA21 études
- Seattle, WA21 études
- Edison, NJ21 études
Autres études à Durham
- Cancer du sein63 études
- Cancer (tous types)58 études
- Cancer du poumon non à petites cellules39 études
- Myélome multiple37 études
- Cancer métastatique33 études
- Leucémie aiguë myéloïde33 études
- Cancer du poumon32 études
- Cancer de la prostate32 études
- Cancer colorectal28 études
- Leucémie lymphocytaire chronique27 études
- Cancer de l'ovaire27 études
- Insuffisance cardiaque26 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.